Fei Shen

7PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2025
Fidelity of Next-Generation Sequencing to Predict Human Epidermal Growth Factor 2 Overexpression Across Solid Tumors.

Mya Tran, Christopher A Fausel, Steven Bray

|Jun 03, 2024
ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.

Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger

|Feb 12, 2024
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE.

Fei Shen, Guanglong Jiang, Santosh Philips

|May 01, 2023
Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.

Fei Shen, Guanglong Jiang, Santosh Philips

|Dec 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.

Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger

Pageof 2